A. Erythrocytes

B. Eosinophils

D. Monocytes

A. Nucleus disintegration

B. Nucleolus disintegration

C. Nuclear basophilia

A. Decreased bleeding time and increased clotting time

B. Increased bleeding time and clotting time

C. Decreased bleeding time and clotting time

A. DIsseminated intravascular coagulation

B. Thiazide therapy

D. Osteopetrosis

A. Hyaline change

B. Atrophy

C. Amy

A. Folic acid level

B. Pancreatic enzyme deficiency

D. Coronary artery disease

B. Hemolytic anemia

C. chronic disease

D. Acute blood loss

A. Mediterranean anemia

B. Erythroblastic anema

D. Beta Thalassemia major

B. Infectious mononucleosis

C. Hodgkins lymphoma

D. Burkitts lymphoma

A. Is a congenital disorder

C. Nerve blocks can be given safely

D. Affects males and females equally

A. Chronic inflammation

B. Liquefactive necrosis

C. Scar tissue

A. Tuberculosis

C. Pertussis

D. Viral infections

A. Plummer Vinson syndrome

B. Sturge weber syndrome

D. Multiple hamartoma syndrome

B. Heart

C. Spleen

D. Liver

B. Periostitis

C. Chronic osteomyelitis

D. Acute osteomyelitis

A. Vitamin B6

B. Vitamin B1

D. Folic acid

B. Scanning electron miscroscopy

C. X-ray crytallography

D. Electron microscopy

B. Lungs

C. Pelvis

D. Clavicle

A. Autolysis

B. Autopsy

D. Lysis

A. Left axillary nodes

B. Right supraclavicular nodes

C. Right axillary nodes

B. Hereditary spherocytosis

C. Sickle cell anemia

D. Thalassemia

B. Neoplastic change in the cell

C. Intracytoplasmic accumulation

D. Degenerative change

A. G2

B. M

C. G1

A. One beta chains and two alpha chains

C. One alpha chains and two beta chains

D. One alpha chain and one beta chain

A. Heterozygous sickle cell trait

B. Homozygous sickle cell anemia

D. Megaloblastic anemia

A. All of the above

B. Phenylalanine for glutamic acid

C. Tyrosine for valine at the 6th position at beta chain

B. Epithelial dysplasia

C. Neo angiogenesis

D. Liquefaction degeneration

A. Caseation yellow fever

B. Gumma infarction

C. Coagulation necrosis Tuberculosis

A. Leukemia

B. Leucocytosis

D. Leucorrhoea

B. a2 microglobulin

C. AL protein

D. a-amyloid protein

B. Acute erythroleukaemia

C. Acute megakaryocytic leukaemia

D. Acute myelomonocytic leukaemia

B. Irreversible injury

C. Both A and B

D. None of the above

A. Intrinsic pathway

B. Platelet function

C. Extrinic pathway

B. Pernicious anemia

C. Aplastic anemia

D. Sickle cell anemia

B. Ileum

C. Intestine

D. Duodenum

A. Infectious mononucleosis

B. Burkitts lymphoma

C. African jaw lymphoma

A. BT

B. PT

C. CBP

B. In hemophilia A females are carriers

C. Hemophilia A is due to deficiency of factor VIII

D. Desmopressin is useful in the management of hemophilia A

A. Hydropic degeneration

C. Amyloid degeneration

D. Fatty degeneration

A. Decrease in platelets

B. Increase in palatelets

C. Increase in hemoglobin

A. Secondary Iues

B. Rabies

C. Actinomycosis

A. Factor XI

C. Factor X

D. Factor IX

A. Macrocytic hyperchromic

C. Macrocytic hypochromic

D. None of the above

A. Capillary dilation

B. Edema

D. Erythrocyte engorgement

A. It is more common in heart, skin and skeletal tissue

B. In 50% of cases have some form of plasma cell dyscrasias such as multiple myeloma

C. In 70% of cases dont have any associated disease

A. Chronic myeloid leukemia

B. Tropical splenomegaly

C. Chronic malaria

A. Caseation

C. Fibrinoid

D. Coagulation

A. Factor VIII concentrate

B. EACA

C. Cryoprecipitate

A. Megaloblastic anemia

B. Hemophilia

C. Aplastic anaemia

A. Necrosis

B. Autolysis

D. None of the above